Bone mineral content in systemic sclerosis measured by photonabsorptiometry

Area of Science:

• Rheumatology
• Endocrinology
• Bone Metabolism

Background:

• Systemic sclerosis is an autoimmune disease characterized by fibrosis and vascular abnormalities.
• Bone density changes are a potential complication, but underlying mechanisms require further investigation.

Purpose of the Study:

• To assess bone mineral content in the radius of patients with systemic sclerosis.
• To investigate potential correlations between bone density and disease-related factors.

Main Methods:

• Bone mineral content was measured using Americium-241 photon absorptiometry in 37 systemic sclerosis patients and matched controls.
• Serum calcium, phosphate, and parathyroid hormone levels, along with urinary calcium and phosphate excretion, were analyzed.

Main Results:

• Patients with systemic sclerosis exhibited significantly reduced bone mineral content in the radius compared to healthy controls (p < 0.05).
• Serum and urinary analyses for calcium, phosphate, and parathyroid hormone were within normal ranges for both groups.

Conclusions:

• Reduced bone mineral content is present in the radius of systemic sclerosis patients.
• Immobilization of affected hands due to disease progression is a potential contributing factor to bone density loss.